Literature DB >> 9798224

The relationship between temporomandibular disorders and stress-associated syndromes.

A Korszun1, E Papadopoulos, M Demitrack, C Engleberg, L Crofford.   

Abstract

OBJECTIVES: The purpose of this study was to determine the comorbidity of temporomandibular disorders and other stress-associated conditions in patients with chronic fatigue syndrome and fibromyalgia. STUDY
DESIGN: Of 92 patients who fulfilled the criteria for chronic fatigue syndrome or fibromyalgia (or both), 39 (42%) reported a prior diagnosis of temporomandibular disorder. Further questionnaires were sent to the members of this group, and 30 patients responded.
RESULTS: Of the original 92 patients, of whom 42% reported temporomandibular disorders, 46% had histories of irritable bowel syndrome, 42% of premenstrual syndrome, and 19% of interstitial cystitis. Of the patients with temporomandibular disorders, the great majority reported an onset of generalized symptoms before the onset of facial pain. Despite this, 75% had been treated exclusively for temporomandibular disorders, usually with bite splints.
CONCLUSIONS: Patients appearing for treatment with chronic facial pain show a high comorbidity with other stress-associated syndromes. The clinical overlap between these conditions may reflect a shared underlying pathophysiologic basis involving dysregulation of the hypothalamic-pituitary-adrenal stress hormone axis in predisposed individuals. A multidisciplinary clinical approach to temporomandibular disorders would improve diagnosis and treatment outcomes for this group of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9798224     DOI: 10.1016/s1079-2104(98)90366-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  26 in total

1.  Stress enhances muscle nociceptor activity in the rat.

Authors:  X Chen; P G Green; J D Levine
Journal:  Neuroscience       Date:  2011-04-15       Impact factor: 3.590

2.  Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.

Authors:  Yolanda R Smith; Christian S Stohler; Thomas E Nichols; Joshua A Bueller; Robert A Koeppe; Jon-Kar Zubieta
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

Review 3.  The role of psychosocial factors in temporomandibular disorders.

Authors:  G B Rollman; J M Gillespie
Journal:  Curr Rev Pain       Date:  2000

Review 4.  Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification.

Authors:  William Maixner; Roger B Fillingim; David A Williams; Shad B Smith; Gary D Slade
Journal:  J Pain       Date:  2016-09       Impact factor: 5.820

5.  High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?

Authors:  Serena Gallotta; Vincenzo Bruno; Santo Catapano; Nicola Mobilio; Carolina Ciacci; Paola Iovino
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 6.  Nonpharmacologic approaches to the management of myofascial temporomandibular disorders.

Authors:  J J Sherman; D C Turk
Journal:  Curr Pain Headache Rep       Date:  2001-10

7.  Stress in the adult rat exacerbates muscle pain induced by early-life stress.

Authors:  Pedro Alvarez; Paul G Green; Jon D Levine
Journal:  Biol Psychiatry       Date:  2013-05-21       Impact factor: 13.382

8.  Development of temporomandibular disorders is associated with greater bodily pain experience.

Authors:  Pei Feng Lim; Shad Smith; Kanokporn Bhalang; Gary D Slade; William Maixner
Journal:  Clin J Pain       Date:  2010-02       Impact factor: 3.442

9.  Temporal summation of heat pain in temporomandibular disorder patients.

Authors:  Karen G Raphael; Malvin N Janal; Sowmya Anathan; Dane B Cook; Roland Staud
Journal:  J Orofac Pain       Date:  2009

Review 10.  Evidence for overlap between urological and nonurological unexplained clinical conditions.

Authors:  María Angeles Bullones Rodríguez; Niloofar Afari; Dedra S Buchwald
Journal:  J Urol       Date:  2009-09-16       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.